These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20470866)

  • 1. Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.
    Chalbot S; Zetterberg H; Blennow K; Fladby T; Grundke-Iqbal I; Iqbal K
    Neurosci Lett; 2010 Jul; 478(3):179-83. PubMed ID: 20470866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease.
    Chalbot S; Zetterberg H; Blennow K; Fladby T; Andreasen N; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2011; 25(3):505-15. PubMed ID: 21471645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease.
    Chalbot S; Zetterberg H; Blennow K; Fladby T; Grundke-Iqbal I; Iqbal K
    Clin Chem; 2009 Dec; 55(12):2171-9. PubMed ID: 19850632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory phospholipase A2 activity in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
    Siroos B; Balood M; Zahednasab H; Mesbah-Namin SA; Pourgholy F; Harirchian MH
    J Neuroimmunol; 2013 Sep; 262(1-2):125-7. PubMed ID: 23859159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients.
    Livrea P; Trojano M; Simone IL; Zimatore GB; Pisicchio L; Logroscino G; Cibelli G
    J Neurol Sci; 1984 Jun; 64(3):245-58. PubMed ID: 6206205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets.
    Hampel H; Kötter HU; Möller HJ
    Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):78-87. PubMed ID: 9194954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias.
    Musaeus CS; Gleerup HS; Høgh P; Waldemar G; Hasselbalch SG; Simonsen AH
    J Alzheimers Dis; 2020; 75(2):429-436. PubMed ID: 32280104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cerebrospinal fluid albumin and immunoglobulin A fractions forecast cortical atrophy and longitudinal functional deterioration in relapsing-remitting multiple sclerosis.
    Kroth J; Ciolac D; Fleischer V; Koirala N; Krämer J; Muthuraman M; Luessi F; Bittner S; Gonzalez-Escamilla G; Zipp F; Meuth SG; Groppa S
    Mult Scler; 2019 Mar; 25(3):338-343. PubMed ID: 29226779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between blood-cerebrospinal fluid barrier dysfunction and the therapeutic effect in tuberculous meningitis patients.
    Tang J; An Y; Liao Y; Li Y; Li L; Wang L
    Eur Neurol; 2014; 71(5-6):331-6. PubMed ID: 24776964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC.
    Alvarez JI; Teale JM
    J Neuroimmunol; 2006 Apr; 173(1-2):45-55. PubMed ID: 16406118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of blood-cerebrospinal fluid barrier in multiple sclerosis.
    Takeoka T; Shinohara Y; Furumi K; Mori K
    J Neurochem; 1983 Oct; 41(4):1102-8. PubMed ID: 6619849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum matrix metalloproteinase-2 levels indicate blood-CSF barrier damage in patients with infectious meningitis.
    Kanoh Y; Ohara T; Kanoh M; Akahoshi T
    Inflammation; 2008 Apr; 31(2):99-104. PubMed ID: 18185989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The choroid plexuses and the barriers between the blood and the cerebrospinal fluid.
    Segal MB
    Cell Mol Neurobiol; 2000 Apr; 20(2):183-96. PubMed ID: 10696509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.
    Wada H
    Intern Med; 1998 Jun; 37(6):509-13. PubMed ID: 9678683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
    Novakova L; Axelsson M; Malmeström C; Zetterberg H; Björkhem I; Karrenbauer VD; Lycke J
    J Neurol Sci; 2015 Nov; 358(1-2):201-6. PubMed ID: 26342940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cerebrospinal fluid and barriers - anatomic and physiologic considerations.
    Tumani H; Huss A; Bachhuber F
    Handb Clin Neurol; 2017; 146():21-32. PubMed ID: 29110772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
    Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
    Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment.
    Zetterberg H; Jakobsson J; Redsäter M; Andreasson U; Pålsson E; Ekman CJ; Sellgren C; Johansson AG; Blennow K; Landén M
    Psychiatry Res; 2014 Jul; 217(3):143-6. PubMed ID: 24745469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.
    Jongen PJ; Doesburg WH; Ibrahim-Stappers JL; Lemmens WA; Hommes OR; Lamers KJ
    Acta Neurol Scand; 2000 Feb; 101(2):116-21. PubMed ID: 10685859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient.
    Castellazzi M; Morotti A; Tamborino C; Alessi F; Pilotto S; Baldi E; Caniatti LM; Trentini A; Casetta I; Granieri E; Pugliatti M; Fainardi E; Bellini T
    Fluids Barriers CNS; 2020 Feb; 17(1):14. PubMed ID: 32024544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.